Matchpoint Therapeutics: Funding, Investors & Team (Oct 2026)
Matchpoint Therapeutics has raised $220M across 2 funding rounds on record, the most recent a Series B of $150M announced in Oct 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Matchpoint Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Matchpoint Therapeutics Funding Rounds
Matchpoint Therapeutics raised $70.0M in a Series A announced in Oct 2022.
4 years later, a Series B of $150M was announced in Oct 2026.
Matchpoint Therapeutics Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Matchpoint Therapeutics Founders and Leadership Team
Contact details for the Matchpoint Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Matchpoint Therapeutics Funding Compared to Other Biotechnology Startups
Matchpoint Therapeutics' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Matchpoint Therapeutics in Biotechnology and Cambridge
Companies Similar to Matchpoint Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Matchpoint Therapeutics Funding FAQs
How much funding has Matchpoint Therapeutics raised?
Matchpoint Therapeutics has raised $220M across 2 rounds on record. The most recent is a Series B of $150M announced in Oct 2026.
When did Matchpoint Therapeutics last raise funding?
Matchpoint Therapeutics' most recent funding round on record is a Series B of $150M, announced in Oct 2026.
Who has invested in Matchpoint Therapeutics?
Investors on record for Matchpoint Therapeutics include Norwest, Invus, Digitalis Ventures, Vertex Ventures HC, Alexandria Venture Investments. FundedIQ records 12 investors in total.
Who is the CEO of Matchpoint Therapeutics?
Andre Turenne is listed as CEO at Matchpoint Therapeutics.
Where is Matchpoint Therapeutics headquartered?
Matchpoint Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Matchpoint Therapeutics have?
Matchpoint Therapeutics is in the 11-50 employee band.
When was Matchpoint Therapeutics founded?
Matchpoint Therapeutics was founded in 2021.
How does Matchpoint Therapeutics' funding compare to other Biotechnology startups?
Matchpoint Therapeutics' latest round of $150M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Matchpoint Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Matchpoint Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.